↓ Skip to main content

Is the standard dose of amoxicillin-clavulanic acid sufficient?

Overview of attention for article published in BMC Pharmacology and Toxicology, July 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
8 X users
facebook
1 Facebook page

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is the standard dose of amoxicillin-clavulanic acid sufficient?
Published in
BMC Pharmacology and Toxicology, July 2014
DOI 10.1186/2050-6511-15-38
Pubmed ID
Authors

Michiel Haeseker, Thomas Havenith, Leo Stolk, Cees Neef, Cathrien Bruggeman, Annelies Verbon

Abstract

The pharmacodynamic (PD) efficacy target of amoxicillin is 40% time above the minimal inhibition concentration (40%T > MIC). Recent studies of other antibiotics have shown that PD-efficacy targets are not always reached. The aim of this study was to evaluate the percentage of hospitalised patients, using amoxicillin/clavulanic acid intravenously (iv), that reach the pharmacodynamic efficacy target 40%T > MIC. Additionally, the association of demographic anthropomorphic and clinical parameters with the pharmacokinetics and pharmacodynamics of amoxicillin were determined.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Unknown 54 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 20%
Student > Ph. D. Student 9 16%
Student > Bachelor 8 15%
Other 5 9%
Student > Postgraduate 4 7%
Other 10 18%
Unknown 8 15%
Readers by discipline Count As %
Medicine and Dentistry 21 38%
Pharmacology, Toxicology and Pharmaceutical Science 13 24%
Biochemistry, Genetics and Molecular Biology 3 5%
Immunology and Microbiology 3 5%
Nursing and Health Professions 2 4%
Other 7 13%
Unknown 6 11%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2022.
All research outputs
#6,715,905
of 24,219,576 outputs
Outputs from BMC Pharmacology and Toxicology
#115
of 461 outputs
Outputs of similar age
#60,547
of 232,983 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#7
of 15 outputs
Altmetric has tracked 24,219,576 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 461 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 232,983 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.